Related Experiment Video
Updated: Jan 3, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Approach to Patients with Eosinophilia
1Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, 4 Memorial Drive, B1-27, Bethesda, MD 20892, USA.
This review covers eosinophilia, a condition detected in blood or tissue counts. It discusses definitions, diagnostic challenges, associated conditions, and future therapeutic targets for eosinophil-related diseases.
Area of Science:
- Hematology
- Immunology
- Pathology
Background:
- Eosinophilia, an increase in eosinophils, can be detected via complete blood counts or tissue biopsies.
- Understanding eosinophil biology is crucial for interpreting these findings.
- Challenges exist in defining tissue eosinophilia compared to blood eosinophilia.
Purpose of the Study:
- To review the basic biology of eosinophils.
- To define blood eosinophilia and discuss challenges in defining tissue eosinophilia.
- To outline conditions associated with eosinophilia and their evaluation.
Main Methods:
- Literature review of basic eosinophil biology.
- Discussion of definitions and diagnostic criteria for blood and tissue eosinophilia.
- Overview of clinical conditions and diagnostic approaches.
Main Results:
- Eosinophilia is identified through routine blood counts and tissue pathology.
- Definitions for blood eosinophilia are established, but tissue eosinophilia presents diagnostic challenges.
- Various conditions are associated with eosinophilia, necessitating a structured evaluation approach.
Conclusions:
- Further research is needed to identify eosinophil-associated diseases responsive to targeted therapies.
- Development of biomarkers for disease activity and diagnosis in eosinophilic conditions is a future challenge.
- Clarifying the role of eosinophils in disease requires ongoing investigation and therapeutic innovation.
More Related Videos
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Nursing Management
First, in...
Asthma-I: Introduction
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

